Evidence map›Paper›PMID 35284893›Full record

ArticleCurrent research in parasitology & vector-borne diseases2021

Towards understanding transfluthrin efficacy in a pyrethroid-resistant strain of the malaria vector

Melanie Nolden, Andreas Brockmann, Ulrich Ebbinghaus-Kintscher, Kai-Uwe Brueggen, Sebastian Horstmann, Mark J I Paine, Ralf Nauen

Open access · goldAbstract read
In one paragraph

Article in Current research in parasitology & vector-borne diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Susceptibility ofCurrent research in parasitology & vector-borne diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Melanie NoldenBayer AG, Crop Science Division, Alfred Nobel Str. 50, D-40789, Monheim am Rhein, Germany.
Andreas BrockmannBayer AG, Crop Science Division, Alfred Nobel Str. 50, D-40789, Monheim am Rhein, Germany.
Ulrich Ebbinghaus-KintscherBayer AG, Crop Science Division, Alfred Nobel Str. 50, D-40789, Monheim am Rhein, Germany.
Kai-Uwe BrueggenBayer AG, Crop Science Division, Alfred Nobel Str. 50, D-40789, Monheim am Rhein, Germany.
Sebastian HorstmannBayer AG, Crop Science Division, Alfred Nobel Str. 50, D-40789, Monheim am Rhein, Germany.
Mark J I PaineDepartment of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, United Kingdom.
Ralf NauenBayer AG, Crop Science Division, Alfred Nobel Str. 50, D-40789, Monheim am Rhein, Germany.
Bayer (Germany) · DELiverpool School of Tropical Medicine · GBUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria vector control interventions rely heavily on the application of insecticides against anopheline mosquitoes, in particular the fast-acting pyrethroids that target insect voltage-gated sodium channels (VGSC). Frequent applications of pyrethroids have resulted in resistance development in the major malaria vectors including

Indexed as

AnophelesAzole fungicidesDeltamethrinFUMOZ-RMalariaP450Pyrethroid resistanceSodium channelSynergists

Identifiers

PMID35284893
PMCPMC8906121
OpenAlexW3185994799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.